REPORTS

Let’s Pullulate and Expand Your Business

Global Immuno-oncology Drugs Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

Jul 13, 2020  |  179 PAGES  |  REPORT CODE: CMM361994
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The Immuno-oncology Drugs is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 4.8% during the forecast period. The research provides insights for the global Immuno-oncology Drugs market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Immuno-oncology Drugs industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

The Snapshot of Global Immuno-oncology Drugs Market Segmentations:

By Players:

  • Amgen, Inc

  • AstraZeneca, Plc

  • Bristol-Myers Squibb

  • Celgene Corporation

  • Eli Lilly and Company

  • Merck & Co

  • Hoffmann-La Roche AG

  • Johnson & Johnson

  • Novartis International AG

  • AbbVie, Inc

  • Pfizer Inc

  • Sanofi SA

  • EMD Serono, Inc

  • Gilead Sciences Inc

  • Prometheus Therapeutics & Diagnostics

  • Aduro BioTech

  • Galena Biopharma

  • Bavarian Nordic

  • Celldex Therapeutics

  • ImmunoCellular Therapeutics

  • Incyte

By Types:

  • Immune Checkpoint Inhibitors

  • Monoclonal Antibodies

  • Cytokine-Based Immunotherapy

  • Cancer Vaccines

  • CAR-T Cell Therapy

By End-User:

  • Hospitals

  • Pharmacies

  • Online Pharmacies

By Regions:

North America

  • United States

  • Canada

  • Mexico

Europe

  • Germany

  • UK

  • France

  • Italy

  • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

  • Spain

  • Belgium

  • Poland

  • Russia

  • Turkey

  • Others

Asia-Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia and New Zealand

  • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

Latin America, Middle East & Africa

  • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

  • Brazil

  • Nigeria

  • South Africa

  • Argentina

  • Others

Table of Contents

1 Report Overview

  • 1.1 Product Definition and Scope

  • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Immuno-oncology Drugs Market

  • 1.3 Market Segmentation by Type

    • 1.3.1 Global Immuno-oncology Drugs Market Size and Growth Rate of Immune Checkpoint Inhibitors from 2014 to 2026

    • 1.3.2 Global Immuno-oncology Drugs Market Size and Growth Rate of Monoclonal Antibodies from 2014 to 2026

    • 1.3.3 Global Immuno-oncology Drugs Market Size and Growth Rate of Cytokine-Based Immunotherapy from 2014 to 2026

    • 1.3.4 Global Immuno-oncology Drugs Market Size and Growth Rate of Cancer Vaccines from 2014 to 2026

    • 1.3.5 Global Immuno-oncology Drugs Market Size and Growth Rate of CAR-T Cell Therapy from 2014 to 2026

  • 1.4 Market Segmentation by End-Users

    • 1.4.1 Global Immuno-oncology Drugs Market Size and Growth Rate of Hospitals from 2014 to 2026

    • 1.4.2 Global Immuno-oncology Drugs Market Size and Growth Rate of Pharmacies from 2014 to 2026

    • 1.4.3 Global Immuno-oncology Drugs Market Size and Growth Rate of Online Pharmacies from 2014 to 2026

  • 1.5 Market Segmentation by Regions

    • 1.5.1 North America Immuno-oncology Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.1 United States Immuno-oncology Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.2 Canada Immuno-oncology Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.3 Mexico Immuno-oncology Drugs Market Size and Growth Rate from 2014 to 2026

    • 1.5.2 Europe Immuno-oncology Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.1 Germany Immuno-oncology Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.2 UK Immuno-oncology Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.3 France Immuno-oncology Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.4 Italy Immuno-oncology Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.5 Nordic Countries Immuno-oncology Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.6 Spain Immuno-oncology Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.7 Belgium Immuno-oncology Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.8 Poland Immuno-oncology Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.9 Russia Immuno-oncology Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.10 Turkey Immuno-oncology Drugs Market Size and Growth Rate from 2014 to 2026

    • 1.5.3 Asia-Pacific Immuno-oncology Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.1 China Immuno-oncology Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.2 Japan Immuno-oncology Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.3 Australia and New Zealand Immuno-oncology Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.4 India Immuno-oncology Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.5 ASEAN Countries Immuno-oncology Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.6 South Korea Immuno-oncology Drugs Market Size and Growth Rate from 2014 to 2026

    • 1.5.4 Latin America, Middle East & Africa Immuno-oncology Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.1 GCC Countries Immuno-oncology Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.2 Brazil Immuno-oncology Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.3 Nigeria Immuno-oncology Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.4 South Africa Immuno-oncology Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.5 Argentina Immuno-oncology Drugs Market Size and Growth Rate from 2014 to 2026

2 Market Trends and Competitive Landscape

  • 2.1 Market Trends and Dynamics

    • 2.1.1 Market Challenges and Restraints 

    • 2.1.2 Market Opportunities and Potentials

    • 2.1.3 Mergers and Acquisitions

  • 2.2 Competitive Landscape Analysis

    • 2.2.1 Industrial Concentration Analysis

    • 2.2.2 Porter's Five Forces Analysis of the Industry

    • 2.2.3 SWOT Analysis for New Entrants

3 Segmentation of Immuno-oncology Drugs Market by Types

  • 3.1 Product Development Trends of Different Types

  • 3.2 Commercial Product Types of Major Vendors

  • 3.3 Competitive Landscape Analysis of Different Types

  • 3.4 Market Size of Immuno-oncology Drugs by Major Types

    • 3.4.1 Immuno-oncology Drugs Market Size and Growth Rate of Immune Checkpoint Inhibitors

    • 3.4.2 Immuno-oncology Drugs Market Size and Growth Rate of Monoclonal Antibodies

    • 3.4.3 Immuno-oncology Drugs Market Size and Growth Rate of Cytokine-Based Immunotherapy

    • 3.4.4 Immuno-oncology Drugs Market Size and Growth Rate of Cancer Vaccines

    • 3.4.5 Immuno-oncology Drugs Market Size and Growth Rate of CAR-T Cell Therapy

4 Segmentation of Immuno-oncology Drugs Market by End-Users

  • 4.1 Downstream Client Analysis by End-Users

  • 4.2 Competitive Landscape Analysis of Different End-Users

  • 4.3 Market Potential Analysis of Different End-Users

  • 4.4 Market Size of Immuno-oncology Drugs by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Immuno-oncology Drugs in Hospitals

    • 4.4.2 Market Size and Growth Rate of Immuno-oncology Drugs in Pharmacies

    • 4.4.3 Market Size and Growth Rate of Immuno-oncology Drugs in Online Pharmacies

5 Market Analysis by Major Regions

  • 5.1 Global Immuno-oncology Drugs Production Analysis by Major Regions

  • 5.2 Global Immuno-oncology Drugs Consumption Analysis by Major Regions

  • 5.3 Global Immuno-oncology Drugs Production, Import, Consumption and Export Analysis by Regions

    • 5.3.1 North America Immuno-oncology Drugs Production, Import, Consumption and Export Analysis 

    • 5.3.2 Europe Immuno-oncology Drugs Production, Import, Consumption and Export Analysis

    • 5.3.3 Asia Pacific Immuno-oncology Drugs Production, Import, Consumption and Export Analysis

    • 5.3.4 Latin America, Middle East & Africa Immuno-oncology Drugs Production, Import, Consumption and Export Analysis

6 Product Commodity of Immuno-oncology Drugs Market in Major Countries

  • 6.1 Top 5 Export Countries in Immuno-oncology Drugs market from 2014 to 2019

    • 6.1.1 Top 5 Export Countries' Export Value Analysis in Immuno-oncology Drugs market from 2014 to 2019

    • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Immuno-oncology Drugs market from 2014 to 2019

  • 6.2 Top 5 Import Countries in Immuno-oncology Drugs market from 2014 to 2019

    • 6.2.1 Top 5 Import Countries' Import Value Analysis in Immuno-oncology Drugs market from 2014 to 2019

    • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Immuno-oncology Drugs market from 2014 to 2019

  • 6.3 Emerging Top 3 Export Countries Analysis

  • 6.4 Emerging Top 3 Import Countries Analysis

7 North America Immuno-oncology Drugs Landscape Analysis

  • 7.1 North America Immuno-oncology Drugs Landscape Analysis by Major Types

  • 7.2 North America Immuno-oncology Drugs Landscape Analysis by Major End-Users

  • 7.3 North America Immuno-oncology Drugs Landscape Analysis by Major Countries

    • 7.3.1 United States Immuno-oncology Drugs Market Volume and Growth Rate

    • 7.3.2 Canada Immuno-oncology Drugs Market Volume and Growth Rate

    • 7.3.3 Mexico Immuno-oncology Drugs Market Volume and Growth Rate

8 Europe Immuno-oncology Drugs Landscape Analysis

  • 8.1 Europe Immuno-oncology Drugs Landscape Analysis by Major Types

  • 8.2 Europe Immuno-oncology Drugs Landscape Analysis by Major End-Users

  • 8.3 Europe Immuno-oncology Drugs Landscape Analysis by Major Countries

    • 8.3.1 Germany Immuno-oncology Drugs Market Volume and Growth Rate

    • 8.3.2 UK Immuno-oncology Drugs Market Volume and Growth Rate

    • 8.3.3 France Immuno-oncology Drugs Market Volume and Growth Rate

    • 8.3.4 Italy Immuno-oncology Drugs Market Volume and Growth Rate

    • 8.3.5 Nordic Countries Immuno-oncology Drugs Market Volume and Growth Rate

    • 8.3.6 Spain Immuno-oncology Drugs Market Volume and Growth Rate

    • 8.3.7 Belgium Immuno-oncology Drugs Market Volume and Growth Rate

    • 8.3.8 Poland Immuno-oncology Drugs Market Volume and Growth Rate

    • 8.3.9 Russia Immuno-oncology Drugs Market Volume and Growth Rate

    • 8.3.10 Turkey Immuno-oncology Drugs Market Volume and Growth Rate

9 Asia Pacific Immuno-oncology Drugs Landscape Analysis

  • 9.1 Asia Pacific Immuno-oncology Drugs Landscape Analysis by Major Types

  • 9.2 Asia Pacific Immuno-oncology Drugs Landscape Analysis by Major End-Users

  • 9.3 Asia Pacific Immuno-oncology Drugs Landscape Analysis by Major Countries

    • 9.3.1 China Immuno-oncology Drugs Market Volume and Growth Rate

    • 9.3.2 Japan Immuno-oncology Drugs Market Volume and Growth Rate

    • 9.3.3 Australia and New Zealand Immuno-oncology Drugs Market Volume and Growth Rate

    • 9.3.4 India Immuno-oncology Drugs Market Volume and Growth Rate

    • 9.3.5 ASEAN Countries Immuno-oncology Drugs Market Volume and Growth Rate

    • 9.3.6 South Korea Immuno-oncology Drugs Market Volume and Growth Rate

10 Latin America, Middle East & Africa Immuno-oncology Drugs Landscape Analysis

  • 10.1 Latin America, Middle East & Africa Immuno-oncology Drugs Landscape Analysis by Major Types

  • 10.2 Latin America, Middle East & Africa Immuno-oncology Drugs Landscape Analysis by Major End-Users

  • 10.3 Latin America, Middle East & Africa Immuno-oncology Drugs Landscape Analysis by Major Countries

    • 10.3.1 GCC Countries Immuno-oncology Drugs Market Volume and Growth Rate

    • 10.3.2 Brazil Immuno-oncology Drugs Market Volume and Growth Rate

    • 10.3.3 Nigeria Immuno-oncology Drugs Market Volume and Growth Rate

    • 10.3.4 South Africa Immuno-oncology Drugs Market Volume and Growth Rate 

    • 10.3.5 Argentina Immuno-oncology Drugs Market Volume and Growth Rate

11 Major Players Profile

  • 11.1 Amgen, Inc

    • 11.1.1 Amgen, Inc Company Profile and Recent Development

    • 11.1.2 Market Performance

    • 11.1.3 Product and Service Introduction

  • 11.2 AstraZeneca, Plc

    • 11.2.1 AstraZeneca, Plc Company Profile and Recent Development

    • 11.2.2 Market Performance

    • 11.2.3 Product and Service Introduction

  • 11.3 Bristol-Myers Squibb

    • 11.3.1 Bristol-Myers Squibb Company Profile and Recent Development

    • 11.3.2 Market Performance

    • 11.3.3 Product and Service Introduction

  • 11.4 Celgene Corporation

    • 11.4.1 Celgene Corporation Company Profile and Recent Development

    • 11.4.2 Market Performance

    • 11.4.3 Product and Service Introduction

  • 11.5 Eli Lilly and Company

    • 11.5.1 Eli Lilly and Company Company Profile and Recent Development

    • 11.5.2 Market Performance

    • 11.5.3 Product and Service Introduction

  • 11.6 Merck & Co

    • 11.6.1 Merck & Co Company Profile and Recent Development

    • 11.6.2 Market Performance

    • 11.6.3 Product and Service Introduction

  • 11.7 Hoffmann-La Roche AG

    • 11.7.1 Hoffmann-La Roche AG Company Profile and Recent Development

    • 11.7.2 Market Performance

    • 11.7.3 Product and Service Introduction

  • 11.8 Johnson & Johnson

    • 11.8.1 Johnson & Johnson Company Profile and Recent Development

    • 11.8.2 Market Performance

    • 11.8.3 Product and Service Introduction

  • 11.9 Novartis International AG

    • 11.9.1 Novartis International AG Company Profile and Recent Development

    • 11.9.2 Market Performance

    • 11.9.3 Product and Service Introduction

  • 11.10 AbbVie, Inc

    • 11.10.1 AbbVie, Inc Company Profile and Recent Development

    • 11.10.2 Market Performance

    • 11.10.3 Product and Service Introduction

  • 11.11 Pfizer Inc

    • 11.11.1 Pfizer Inc Company Profile and Recent Development

    • 11.11.2 Market Performance

    • 11.11.3 Product and Service Introduction

  • 11.12 Sanofi SA

    • 11.12.1 Sanofi SA Company Profile and Recent Development

    • 11.12.2 Market Performance

    • 11.12.3 Product and Service Introduction

  • 11.13 EMD Serono, Inc

    • 11.13.1 EMD Serono, Inc Company Profile and Recent Development

    • 11.13.2 Market Performance

    • 11.13.3 Product and Service Introduction

  • 11.14 Gilead Sciences Inc

    • 11.14.1 Gilead Sciences Inc Company Profile and Recent Development

    • 11.14.2 Market Performance

    • 11.14.3 Product and Service Introduction

  • 11.15 Prometheus Therapeutics & Diagnostics

    • 11.15.1 Prometheus Therapeutics & Diagnostics Company Profile and Recent Development

    • 11.15.2 Market Performance

    • 11.15.3 Product and Service Introduction

  • 11.16 Aduro BioTech

    • 11.16.1 Aduro BioTech Company Profile and Recent Development

    • 11.16.2 Market Performance

    • 11.16.3 Product and Service Introduction

  • 11.17 Galena Biopharma

    • 11.17.1 Galena Biopharma Company Profile and Recent Development

    • 11.17.2 Market Performance

    • 11.17.3 Product and Service Introduction

  • 11.18 Bavarian Nordic

    • 11.18.1 Bavarian Nordic Company Profile and Recent Development

    • 11.18.2 Market Performance

    • 11.18.3 Product and Service Introduction

  • 11.19 Celldex Therapeutics

    • 11.19.1 Celldex Therapeutics Company Profile and Recent Development

    • 11.19.2 Market Performance

    • 11.19.3 Product and Service Introduction

  • 11.20 ImmunoCellular Therapeutics

    • 11.20.1 ImmunoCellular Therapeutics Company Profile and Recent Development

    • 11.20.2 Market Performance

    • 11.20.3 Product and Service Introduction

  • 11.21 Incyte

    • 11.21.1 Incyte Company Profile and Recent Development

    • 11.21.2 Market Performance

    • 11.21.3 Product and Service Introduction

12 Data Source and Research Methodology

The List of Tables and Figures (Totals 88 Figures and 131 Tables)

  • Figure Product Picture

  • Figure Immuno-oncology Drugs Market Size and Growth Rate of Immune Checkpoint Inhibitors from 2014 to 2026

  • Figure Immuno-oncology Drugs Market Size and Growth Rate of Monoclonal Antibodies from 2014 to 2026

  • Figure Immuno-oncology Drugs Market Size and Growth Rate of Cytokine-Based Immunotherapy from 2014 to 2026

  • Figure Immuno-oncology Drugs Market Size and Growth Rate of Cancer Vaccines from 2014 to 2026

  • Figure Immuno-oncology Drugs Market Size and Growth Rate of CAR-T Cell Therapy from 2014 to 2026

  • Figure Market Share by Type in 2014

  • Figure Market Share by Type in 2018

  • Figure Market Share by Type in 2026

  • Figure Global Immuno-oncology Drugs Market Size and Growth Rate of Hospitals from 2014 to 2026

  • Figure Global Immuno-oncology Drugs Market Size and Growth Rate of Pharmacies from 2014 to 2026

  • Figure Global Immuno-oncology Drugs Market Size and Growth Rate of Online Pharmacies from 2014 to 2026

  • Figure Market Share by End-User in 2014

  • Figure Market Share by End-User in 2018

  • Figure Market Share by End-User in 2026

  • Figure North America Immuno-oncology Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure United States Immuno-oncology Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Canada Immuno-oncology Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Mexico Immuno-oncology Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Europe Immuno-oncology Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Germany Immuno-oncology Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure UK Immuno-oncology Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure France Immuno-oncology Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Italy Immuno-oncology Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Nordic Countries Immuno-oncology Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Spain Immuno-oncology Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Belgium Immuno-oncology Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Poland Immuno-oncology Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Russia Immuno-oncology Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Turkey Immuno-oncology Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Asia-Pacific Immuno-oncology Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure China Immuno-oncology Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Japan Immuno-oncology Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Australia and New Zealand Immuno-oncology Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure India Immuno-oncology Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure ASEAN Countries Immuno-oncology Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure South Korea Immuno-oncology Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Latin America, Middle East & Africa Immuno-oncology Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure GCC Countries Immuno-oncology Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Brazil Immuno-oncology Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Nigeria Immuno-oncology Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure South Africa Immuno-oncology Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Argentina Immuno-oncology Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Development Trends and Industry Dynamics of Immuno-oncology Drugs Industry

  • Figure Market Challenges and Restraints

  • Figure Market Opportunities and Potentials

  • Table Mergers and Acquisition

  • Figure Market Share of TOP 3 Players in 2018

  • Figure Market Share of TOP 5 Players in 2018

  • Figure Market Share of TOP 6 Players from 2014 to 2019

  • Figure Porter's Five Forces Analysis

  • Figure New Entrant SWOT Analysis

  • Table Specifications of Different Types of Immuno-oncology Drugs

  • Figure Development Trends of Different Types

  • Table Commercial Products Types of Major Vendors

  • Figure Competitive Landscape Analysis of Different Types

  • Table Consumption of Immuno-oncology Drugs by Different Types from 2014 to 2026

  • Table Consumption Share of Immuno-oncology Drugs by Different Types from 2014 to 2026

  • Figure Market Size and Growth Rate of Immune Checkpoint Inhibitors

  • Figure Market Size and Growth Rate of Monoclonal Antibodies

  • Figure Market Size and Growth Rate of Cytokine-Based Immunotherapy

  • Figure Market Size and Growth Rate of Cancer Vaccines

  • Figure Market Size and Growth Rate of CAR-T Cell Therapy

  • Table Downstream Client Analysis by End-Users

  • Figure Competitive Landscape Analysis of Different End-Users

  • Table Market Potential Analysis of Different End-Users

  • Table Consumption of Immuno-oncology Drugs by Different End-Users from 2014 to 2026

  • Table Consumption Share of Immuno-oncology Drugs by Different End-Users from 2014 to 2026

  • Figure Market Size and Growth Rate of Hospitals

  • Figure Market Size and Growth Rate of Pharmacies

  • Figure Market Size and Growth Rate of Online Pharmacies

  • Table Global Immuno-oncology Drugs Production by Major Regions

  • Table Global Immuno-oncology Drugs Production Share by Major Regions

  • Figure Global Immuno-oncology Drugs Production Share by Major Regions in 2014

  • Figure Global Immuno-oncology Drugs Production Share by Major Regions in 2018

  • Figure Global Immuno-oncology Drugs Production Share by Major Regions in 2026

  • Table Global Immuno-oncology Drugs Consumption by Major Regions

  • Table Global Immuno-oncology Drugs Consumption Share by Major Regions

  • Figure Global Immuno-oncology Drugs Consumption Share by Major Regions in 2014

  • Figure Global Immuno-oncology Drugs Consumption Share by Major Regions in 2018

  • Figure Global Immuno-oncology Drugs Consumption Share by Major Regions in 2026

  • Table North America Immuno-oncology Drugs Production, Import, Consumption and Export Analysis

  • Table Europe Immuno-oncology Drugs Production, Import, Consumption and Export Analysis

  • Table Asia Pacific Immuno-oncology Drugs Production, Import, Consumption and Export Analysis

  • Table Latin America, Middle East & Africa Immuno-oncology Drugs Production, Import, Consumption and Export Analysis

  • Table Top 5 Export Countries' Export Value Analysis in Immuno-oncology Drugs market from 2014 to 2019

  • Table Top 5 Export Countries' Export Volume Analysis in Immuno-oncology Drugs market from 2014 to 2019

  • Table Top 5 Import Countries' Import Value Analysis in Immuno-oncology Drugs market from 2014 to 2019

  • Table Top 5 Import Countries' Import Volume Analysis in Immuno-oncology Drugs market from 2014 to 2019

  • Figure Emerging Top 3 Export Countries Analysis

  • Figure Emerging Top 3 Import Countries Analysis

  • Table North America Immuno-oncology Drugs Consumption by Types from 2014 to 2026

  • Table North America Immuno-oncology Drugs Consumption Share by Types from 2014 to 2026

  • Figure North America Immuno-oncology Drugs Consumption Share by Types in 2014

  • Figure North America Immuno-oncology Drugs Consumption Share by Types in 2018

  • Figure North America Immuno-oncology Drugs Consumption Share by Types in 2026

  • Table North America Immuno-oncology Drugs Consumption by End-Users from 2014 to 2026

  • Table North America Immuno-oncology Drugs Consumption Share by End-Users from 2014 to 2026

  • Figure North America Immuno-oncology Drugs Consumption Share by End-Users in 2014

  • Figure North America Immuno-oncology Drugs Consumption Share by End-Users in 2018

  • Figure North America Immuno-oncology Drugs Consumption Share by End-Users in 2026

  • Table North America Immuno-oncology Drugs Consumption by Major Countries from 2014 to 2026

  • Table North America Immuno-oncology Drugs Consumption Share by Major Countries from 2014 to 2026

  • Figure North America Immuno-oncology Drugs Consumption Share by Major Countries in 2014

  • Figure North America Immuno-oncology Drugs Consumption Share by Major Countries in 2018

  • Figure North America Immuno-oncology Drugs Consumption Share by Major Countries in 2026

  • Figure United States Immuno-oncology Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure Canada Immuno-oncology Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure Mexico Immuno-oncology Drugs Market Volume and Growth Rate from 2014 to 2026

  • Table Europe Immuno-oncology Drugs Consumption by Types from 2014 to 2026

  • Table Europe Immuno-oncology Drugs Consumption Share by Types from 2014 to 2026

  • Figure Europe Immuno-oncology Drugs Consumption Share by Types in 2014

  • Figure Europe Immuno-oncology Drugs Consumption Share by Types in 2018

  • Figure Europe Immuno-oncology Drugs Consumption Share by Types in 2026

  • Table Europe Immuno-oncology Drugs Consumption by End-Users from 2014 to 2026

  • Table Europe Immuno-oncology Drugs Consumption Share by End-Users from 2014 to 2026

  • Figure Europe Immuno-oncology Drugs Consumption Share by End-Users in 2014

  • Figure Europe Immuno-oncology Drugs Consumption Share by End-Users in 2018

  • Figure Europe Immuno-oncology Drugs Consumption Share by End-Users in 2026

  • Table Europe Immuno-oncology Drugs Consumption by Major Countries from 2014 to 2026

  • Table Europe Immuno-oncology Drugs Consumption Share by Major Countries from 2014 to 2026

  • Figure Europe Immuno-oncology Drugs Consumption Share by Major Countries in 2014

  • Figure Europe Immuno-oncology Drugs Consumption Share by Major Countries in 2018

  • Figure Europe Immuno-oncology Drugs Consumption Share by Major Countries in 2026

  • Figure Germany Immuno-oncology Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure UK Immuno-oncology Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure France Immuno-oncology Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure Italy Immuno-oncology Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure Nordic Countries Immuno-oncology Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure Belgium Immuno-oncology Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure Poland Immuno-oncology Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure Russia Immuno-oncology Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure Turkey Immuno-oncology Drugs Market Volume and Growth Rate from 2014 to 2026

  • Table Asia Pacific Immuno-oncology Drugs Consumption by Types from 2014 to 2026

  • Table Asia Pacific Immuno-oncology Drugs Consumption Share by Types from 2014 to 2026

  • Figure Asia Pacific Immuno-oncology Drugs Consumption Share by Types in 2014

  • Figure Asia Pacific Immuno-oncology Drugs Consumption Share by Types in 2018

  • Figure Asia Pacific Immuno-oncology Drugs Consumption Share by Types in 2026

  • Table Asia Pacific Immuno-oncology Drugs Consumption by End-Users from 2014 to 2026

  • Table Asia Pacific Immuno-oncology Drugs Consumption Share by End-Users from 2014 to 2026

  • Figure Asia Pacific Immuno-oncology Drugs Consumption Share by End-Users in 2014

  • Figure Asia Pacific Immuno-oncology Drugs Consumption Share by End-Users in 2018

  • Figure Asia Pacific Immuno-oncology Drugs Consumption Share by End-Users in 2026

  • Table Asia Pacific Immuno-oncology Drugs Consumption by Major Countries from 2014 to 2026

  • Table Asia Pacific Immuno-oncology Drugs Consumption Share by Major Countries from 2014 to 2026

  • Figure Asia Pacific Immuno-oncology Drugs Consumption Share by Major Countries in 2014

  • Figure Asia Pacific Immuno-oncology Drugs Consumption Share by Major Countries in 2018

  • Figure Asia Pacific Immuno-oncology Drugs Consumption Share by Major Countries in 2026

  • Figure China Immuno-oncology Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure Japan Immuno-oncology Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure Australia and New ZealandImmuno-oncology Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure India Immuno-oncology Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure ASEAN Countries Immuno-oncology Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure South Korea Immuno-oncology Drugs Market Volume and Growth Rate from 2014 to 2026

  • Table Latin America, Middle East & Africa Immuno-oncology Drugs Consumption by Types from 2014 to 2026

  • Table Latin America, Middle East & Africa Immuno-oncology Drugs Consumption Share by Types from 2014 to 2026

  • Figure Latin America, Middle East & Africa Immuno-oncology Drugs Consumption Share by Types in 2014

  • Figure Latin America, Middle East & Africa Immuno-oncology Drugs Consumption Share by Types in 2018

  • Figure Latin America, Middle East & Africa Immuno-oncology Drugs Consumption Share by Types in 2026

  • Table Latin America, Middle East & Africa Immuno-oncology Drugs Consumption by End-Users from 2014 to 2026

  • Table Latin America, Middle East & Africa Immuno-oncology Drugs Consumption Share by End-Users from 2014 to 2026

  • Figure Latin America, Middle East & Africa Immuno-oncology Drugs Consumption Share by End-Users in 2014

  • Figure Latin America, Middle East & Africa Immuno-oncology Drugs Consumption Share by End-Users in 2018

  • Figure Latin America, Middle East & Africa Immuno-oncology Drugs Consumption Share by End-Users in 2026

  • Table Latin America, Middle East & Africa Immuno-oncology Drugs Consumption by Major Countries from 2014 to 2026

  • Table Latin America, Middle East & Africa Immuno-oncology Drugs Consumption Share by Major Countries from 2014 to 2026

  • Figure Latin America, Middle East & Africa Immuno-oncology Drugs Consumption Share by Major Countries in 2014

  • Figure Latin America, Middle East & Africa Immuno-oncology Drugs Consumption Share by Major Countries in 2018

  • Figure Latin America, Middle East & Africa Immuno-oncology Drugs Consumption Share by Major Countries in 2026

  • Figure GCC Countries Immuno-oncology Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure Brazil Immuno-oncology Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure Nigeria Immuno-oncology Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure South Africa Immuno-oncology Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure Argentina Immuno-oncology Drugs Market Volume and Growth Rate from 2014 to 2026

  • Table Company Profile and Development Status of Amgen, Inc

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen, Inc

  • Figure Sales and Growth Rate Analysis of Amgen, Inc

  • Figure Revenue and Market Share Analysis of Amgen, Inc

  • Table Product and Service Introduction of Amgen, Inc

  • Table Company Profile and Development Status of AstraZeneca, Plc

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca, Plc

  • Figure Sales and Growth Rate Analysis of AstraZeneca, Plc

  • Figure Revenue and Market Share Analysis of AstraZeneca, Plc

  • Table Product and Service Introduction of AstraZeneca, Plc

  • Table Company Profile and Development Status of Bristol-Myers Squibb

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb

  • Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb

  • Figure Revenue and Market Share Analysis of Bristol-Myers Squibb

  • Table Product and Service Introduction of Bristol-Myers Squibb

  • Table Company Profile and Development Status of Celgene Corporation

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celgene Corporation

  • Figure Sales and Growth Rate Analysis of Celgene Corporation

  • Figure Revenue and Market Share Analysis of Celgene Corporation

  • Table Product and Service Introduction of Celgene Corporation

  • Table Company Profile and Development Status of Eli Lilly and Company

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly and Company

  • Figure Sales and Growth Rate Analysis of Eli Lilly and Company

  • Figure Revenue and Market Share Analysis of Eli Lilly and Company

  • Table Product and Service Introduction of Eli Lilly and Company

  • Table Company Profile and Development Status of Merck & Co

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck & Co

  • Figure Sales and Growth Rate Analysis of Merck & Co

  • Figure Revenue and Market Share Analysis of Merck & Co

  • Table Product and Service Introduction of Merck & Co

  • Table Company Profile and Development Status of Hoffmann-La Roche AG

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hoffmann-La Roche AG

  • Figure Sales and Growth Rate Analysis of Hoffmann-La Roche AG

  • Figure Revenue and Market Share Analysis of Hoffmann-La Roche AG

  • Table Product and Service Introduction of Hoffmann-La Roche AG

  • Table Company Profile and Development Status of Johnson & Johnson

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson

  • Figure Sales and Growth Rate Analysis of Johnson & Johnson

  • Figure Revenue and Market Share Analysis of Johnson & Johnson

  • Table Product and Service Introduction of Johnson & Johnson

  • Table Company Profile and Development Status of Novartis International AG

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis International AG

  • Figure Sales and Growth Rate Analysis of Novartis International AG

  • Figure Revenue and Market Share Analysis of Novartis International AG

  • Table Product and Service Introduction of Novartis International AG

  • Table Company Profile and Development Status of AbbVie, Inc

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AbbVie, Inc

  • Figure Sales and Growth Rate Analysis of AbbVie, Inc

  • Figure Revenue and Market Share Analysis of AbbVie, Inc

  • Table Product and Service Introduction of AbbVie, Inc

  • Table Company Profile and Development Status of Pfizer Inc

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer Inc

  • Figure Sales and Growth Rate Analysis of Pfizer Inc

  • Figure Revenue and Market Share Analysis of Pfizer Inc

  • Table Product and Service Introduction of Pfizer Inc

  • Table Company Profile and Development Status of Sanofi SA

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi SA

  • Figure Sales and Growth Rate Analysis of Sanofi SA

  • Figure Revenue and Market Share Analysis of Sanofi SA

  • Table Product and Service Introduction of Sanofi SA

  • Table Company Profile and Development Status of EMD Serono, Inc

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of EMD Serono, Inc

  • Figure Sales and Growth Rate Analysis of EMD Serono, Inc

  • Figure Revenue and Market Share Analysis of EMD Serono, Inc

  • Table Product and Service Introduction of EMD Serono, Inc

  • Table Company Profile and Development Status of Gilead Sciences Inc

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Gilead Sciences Inc

  • Figure Sales and Growth Rate Analysis of Gilead Sciences Inc

  • Figure Revenue and Market Share Analysis of Gilead Sciences Inc

  • Table Product and Service Introduction of Gilead Sciences Inc

  • Table Company Profile and Development Status of Prometheus Therapeutics & Diagnostics

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Prometheus Therapeutics & Diagnostics

  • Figure Sales and Growth Rate Analysis of Prometheus Therapeutics & Diagnostics

  • Figure Revenue and Market Share Analysis of Prometheus Therapeutics & Diagnostics

  • Table Product and Service Introduction of Prometheus Therapeutics & Diagnostics

  • Table Company Profile and Development Status of Aduro BioTech

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Aduro BioTech

  • Figure Sales and Growth Rate Analysis of Aduro BioTech

  • Figure Revenue and Market Share Analysis of Aduro BioTech

  • Table Product and Service Introduction of Aduro BioTech

  • Table Company Profile and Development Status of Galena Biopharma

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Galena Biopharma

  • Figure Sales and Growth Rate Analysis of Galena Biopharma

  • Figure Revenue and Market Share Analysis of Galena Biopharma

  • Table Product and Service Introduction of Galena Biopharma

  • Table Company Profile and Development Status of Bavarian Nordic

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bavarian Nordic

  • Figure Sales and Growth Rate Analysis of Bavarian Nordic

  • Figure Revenue and Market Share Analysis of Bavarian Nordic

  • Table Product and Service Introduction of Bavarian Nordic

  • Table Company Profile and Development Status of Celldex Therapeutics

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celldex Therapeutics

  • Figure Sales and Growth Rate Analysis of Celldex Therapeutics

  • Figure Revenue and Market Share Analysis of Celldex Therapeutics

  • Table Product and Service Introduction of Celldex Therapeutics

  • Table Company Profile and Development Status of ImmunoCellular Therapeutics

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of ImmunoCellular Therapeutics

  • Figure Sales and Growth Rate Analysis of ImmunoCellular Therapeutics

  • Figure Revenue and Market Share Analysis of ImmunoCellular Therapeutics

  • Table Product and Service Introduction of ImmunoCellular Therapeutics

  • Table Company Profile and Development Status of Incyte

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Incyte

  • Figure Sales and Growth Rate Analysis of Incyte

  • Figure Revenue and Market Share Analysis of Incyte

  • Table Product and Service Introduction of Incyte


Report Purchase

reports
$4480
$8960
BUY NOWClick MeBUY NOW
top